Evidence map›Paper›PMID 36290825›Full record

SynthesisCurrent oncology (Toronto, Ont.)2022

Lung Metastatectomy: Can Laser-Assisted Surgery Make a Difference?

Konstantinos Grapatsas, Anastasia Papaporfyriou, Vasileios Leivaditis, Benjamin Ehle, Michail Galanis

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Advancements in prognostic factors and survival outcomes following pulmonary metastasectomy for head and neck cancers.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2024
    Review
  4. Enhancing treatment approaches for postpneumonectomy empyema: exploring the role of video-assisted thoracic surgery.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Radiomics in Lung Metastases: A Systematic Review.Journal of personalized medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Konstantinos GrapatsasDepartment of Thoracic Surgery, University Clinic Ostwestfalen-Lippe, Campus Bielefeld, 33604 Bielefeld, Germany.
Anastasia PapaporfyriouDivision of Pulmonology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5479-4649
Vasileios LeivaditisDepartment of Cardiothoracic and Vascular Surgery, Westpfalz-Klinikum, 67655 Kaiserslautern, Germany.
Benjamin EhleDepartment of General, Visceral, Thoracic and Oncological Surgery, Helios Amper Hospital Dachau, 85221 Dachau, Germany.
Michail GalanisDepartment of Thoracic Surgery, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.
Helios Amper-Klinikum Dachau · DEMedical University of Vienna · ATUniversity of Bern · CHWestpfalz Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundResection of lung metastases with curative intention in selected patients is associated with prolonged survival. Laser-assisted resection of lung metastases results in complete resection of a high number of lung metastases, while preserving lung parenchyma. However, data concerning laser lung resections are scarce and contradictory. The aim of this study was to conduct a systematic review to evaluate the utility of laser-assisted pulmonary metastasectomy.

methodsAn electronic search in MEDLINE (via PubMed), complemented by manual searches in article references, was conducted to identify eligible studies.

resultsFourteen studies with a total of 1196 patients were included in this metanalysis. Laser-assisted surgery (LAS) for lung metastases is a safe procedure with a postoperative morbidity up to 24.2% and almost zero mortality. LAS resulted in the resection of a high number of lung metastases with reduction of the lung parenchyma loss in comparison with conventional resection methods. Survival was similar between LAS and conventional resections.

conclusionLAS allows radical lung-parenchyma saving resection of a high number of lung metastases with similar survival to conventional methods.

Indexed as

Laser TherapyLung NeoplasmsMetastasectomyHumansLungRetrospective Studieslaserlaser-assistedlung metastasesmetastasesmorbiditypostoperative complicationspulmonary metastasectomy

Identifiers

PMID36290825
PMCPMC9600252
OpenAlexW4297348327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.